Salvage Therapy

Individuals who ranked highest on a scale measuring social vulnerability by location had a poorer prognosis following colorectal resection, according to a presentation at Southern Surgical Association Annual Meeting.

The American Urological Association released a clinical practice guideline pertaining to salvage therapy for men with prostate cancer.

Delaying salvage radiation therapy after radical prostatectomy for men with just one high-risk factor for prostate cancer recurrence may significantly increase risk for all-cause mortality, a study in Journal of Clinical Oncology showed.

Patients with multiple myeloma who relapse after B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy may benefit from “subsequent T-cell redirection,” according to researchers.

In this video, Kara N. Babaian, MD, highlighted three presentations from the American Urological Association meeting that reported on salvage treatment following focal therapy.

Pembrolizumab plus gemcitabine, vinorelbine and liposomal doxorubicin, or GVD, was an effective second-line therapy in patients with relapsed or refractory classical Hodgkin lymphoma, according to a phase 2 study presented at the ASH Annual Meeting and Exposition.

PSA level prior to salvage radiotherapy may be a prognostic biomarker for clinical outcomes of long-term antiandrogen therapy with salvage radiotherapy among men with prostate cancer, according to results of a secondary analysis of a randomized trial published in JAMA Oncology.

Researchers found that real-time peer auditing reduced the rate of central-line-associated bloodstream infections in a North Caroline hospital by 12%. This was one of the top stories in infectious disease last week.

Earlier initiation of treatment with a combination of daptomycin and ceftaroline for persistent MRSA bacteremia may make the treatment more effective, rather than delaying its use for salvage therapy, researchers reported in Open Forum Infectious Diseases.

ORLANDO — Quizartinib significantly prolonged survival compared with salvage chemotherapy among patients with relapsed or refractory acute myeloid leukemia and high FLT3-internal tandem duplication variant allele frequency, according to prospective results presented at ASH Annual Meeting and Exposition.